KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other financing activities: 2018-2019

Historic Other financing activities for Adaptive Biotechnologies (ADPT) over the last 2 years, with Sep 2019 value amounting to $1.6 million.

  • Adaptive Biotechnologies' Other financing activities rose 32620.00% to $1.6 million in Q3 2019 from the same period last year, while for Sep 2019 it was $5.0 million, marking a year-over-year change of. This contributed to the annual value of $321,000 for FY2020, which is 93.56% down from last year.
  • As of Q3 2019, Adaptive Biotechnologies' Other financing activities stood at $1.6 million, which was down 51.69% from $3.4 million recorded in Q2 2019.
  • Over the past 5 years, Adaptive Biotechnologies' Other financing activities peaked at $3.4 million during Q2 2019, and registered a low of -$11,000 during Q2 2018.
  • For the 2-year period, Adaptive Biotechnologies' Other financing activities averaged around $827,500, with its median value being -$5,000 (2018).
  • Data for Adaptive Biotechnologies' Other financing activities shows a peak YoY skyrocketed of 32,620.00% (in 2019) over the last 5 years.
  • Adaptive Biotechnologies' Other financing activities (Quarterly) stood at -$5,000 in 2018, then skyrocketed by 32,620.00% to $1.6 million in 2019.
  • Its last three reported values are $1.6 million in Q3 2019, $3.4 million for Q2 2019, and -$6,000 during Q1 2019.